<VariationArchive VariationID="1354843" VariationName="NM_019098.5(CNGB3):c.2105del (p.Lys702fs)" VariationType="Deletion" Accession="VCV001354843" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2022-03-28" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1434428" VariationID="1354843">
      <GeneList>
        <Gene Symbol="CNGB3" FullName="cyclic nucleotide gated channel subunit beta 3" GeneID="54714" HGNC_ID="HGNC:2153" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="86574179" stop="86743634" display_start="86574179" display_stop="86743634" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="87586162" stop="87755902" display_start="87586162" display_stop="87755902" Strand="-" />
          </Location>
          <OMIM>605080</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_019098.5(CNGB3):c.2105del (p.Lys702fs)</Name>
      <CanonicalSPDI>NC_000008.11:86576128:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="86576129" stop="86576129" display_start="86576129" display_stop="86576129" variantLength="1" positionVCF="86576128" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="87588357" stop="87588357" display_start="87588357" display_stop="87588357" variantLength="1" positionVCF="87588356" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K702fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.87588358del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.87588358del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.86576130del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.86576130del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016980.1" sequenceAccession="NG_016980" sequenceVersion="1" change="g.172547del">
            <Expression>NG_016980.1:g.172547del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_019098.5" sequenceAccession="NM_019098" sequenceVersion="5" change="c.2105del" MANESelect="true">
            <Expression>NM_019098.5:c.2105del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_061971.3" sequenceAccession="NP_061971" sequenceVersion="3" change="p.Lys702fs">
            <Expression>NP_061971.3:p.Lys702fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_019098.4" sequenceAccession="NM_019098" sequenceVersion="4" change="c.2105delA">
            <Expression>NM_019098.4:c.2105delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2131529670" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_019098.5(CNGB3):c.2105del (p.Lys702fs) AND not provided" Accession="RCV001876349" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_019098.5(CNGB3):c.2105del (p.Lys702fs) AND Achromatopsia 3" Accession="RCV004594599" Version="1">
        <ClassifiedConditionList TraitSetID="1447">
          <ClassifiedCondition DB="MedGen" ID="C1849792">Achromatopsia 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-16" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16379026</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23805033</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28795510</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1447" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="117" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ROD MONOCHROMACY 1</ElementValue>
                <XRef Type="MIM" ID="262300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ROD MONOCHROMATISM 1</ElementValue>
                <XRef Type="MIM" ID="262300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pingelapese blindness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Achromatopsia with myopia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Total colorblindness with myopia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ACHM1 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rod monochromatism 1 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rod monochromacy 1 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RMCH1 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Achromatopsia 3</ElementValue>
                <XRef ID="MONDO:0009875" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ACHM1</ElementValue>
                <XRef Type="MIM" ID="262300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CNGB3</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ACHM3</ElementValue>
                <XRef Type="MIM" ID="262300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RMCH1</ElementValue>
                <XRef Type="MIM" ID="262300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Achromatopsia is characterized by reduced visual acuity, pendular nystagmus, increased sensitivity to light (photophobia), a small central scotoma, eccentric fixation, and reduced or complete loss of color discrimination. All individuals with achromatopsia (achromats) have impaired color discrimination along all three axes of color vision corresponding to the three cone classes: the protan or long-wavelength-sensitive cone axis (red), the deutan or middle-wavelength-sensitive cone axis (green), and the tritan or short-wavelength-sensitive cone axis (blue). Most individuals have complete achromatopsia, with total lack of function of all three types of cones. Rarely, individuals have incomplete achromatopsia, in which one or more cone types may be partially functioning. The manifestations are similar to those of individuals with complete achromatopsia, but generally less severe. Hyperopia is common in achromatopsia. Nystagmus develops during the first few weeks after birth followed by increased sensitivity to bright light. Best visual acuity varies with severity of the disease; it is 20/200 or less in complete achromatopsia and may be as high as 20/80 in incomplete achromatopsia. Visual acuity is usually stable over time; both nystagmus and sensitivity to bright light may improve slightly. Although the fundus is usually normal, macular changes (which may show early signs of progression) and vessel narrowing may be present in some affected individuals. Defects in the macula are visible on optical coherence tomography.</Attribute>
                <XRef ID="NBK1418" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9650" />
                <XRef ID="9650" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301591</ID>
                <ID Source="BookShelf">NBK1418</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="pmc">3110037</ID>
              </Citation>
              <XRef ID="49382" DB="Orphanet" />
              <XRef ID="C1849792" DB="MedGen" />
              <XRef ID="MONDO:0009875" DB="MONDO" />
              <XRef Type="MIM" ID="262300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4145248" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="14048914|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002118092" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant results in an extension of the CNGB3 protein. Other variant(s) that result in a similarly extended protein product (p.Glu729Metfs*99) have been determined to be pathogenic (Invitae). This suggests that these extensions are likely to be causative of disease. This variant has not been reported in the literature in individuals with CNGB3-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a frameshift in the CNGB3 gene (p.Lys702Argfs*127). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 108 amino acid(s) of the CNGB3 protein and extend the protein by 18 additional amino acid residues.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CNGB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.87588357del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9874667" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_019098_4_CNGB3_c_2105delA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005086161" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16379026</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23805033</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28795510</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are known mechanisms of disease in this gene and are associated with achromatopsia 3 (MIM#262300) (PMIDs: 16379026, 23805033). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0208 - Variant is predicted to result in an elongated protein. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0701 - Other downstream elongation variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. Three elongation variant have been classified as pathogenic by a clinical laboratory in ClinVar, and another two elongation variants have been seen in families with achromatopsia in the literature (PMID: 28795510). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. This variant has been classified as pathogenic by a clinical laboratory in ClinVar. (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CNGB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_20965</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_019098.4:c.2105delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="262300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4145248" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9874667" TraitType="Disease" MappingType="XRef" MappingValue="262300" MappingRef="OMIM">
        <MedGen CUI="C1849792" Name="Achromatopsia 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

